
Customers may bear some cost of U.S. tariff rise, says Natco Pharma CEO
The Hindu
Natco Pharma CEO discusses impact of U.S. tariffs on Indian pharma industry and strategies for diversification and growth.
More Related News

Natco Pharma CEO discusses impact of U.S. tariffs on Indian pharma industry and strategies for diversification and growth.